Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This purpose of this study is to investigate whether ATL-104 is safe and well tolerated, and whether it shows evidence of efficacy in mucositis in patients undergoing PBSCT

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alizyme

Criteria

Inclusion Criteria:

• Patients with haematological malignancies undergoing chemotherapy in association with PBSCT

Exclusion Criteria:

• Clinically significant conditions that would exclude the patient receiving chemotherapy in association with PBSCT

• Visible oral disease

• Significantly reduced platelet and neutrophil count